Happy #FDAFriday! A "Teaching Resource Guide" was released by the FDA as a toolkit to educate health care professionals about biologics, mainly focusing on biosimilars and interchangeable biosimilars. *Sarfaraz K. Niazi, PhD, provides clarity on the: - goals and objectives - 2 levels of learning - types of resources - additional FDA resources "This resource is critical for helping health care professionals engage in informed decision-making and patient education regarding biosimilars, which are increasingly important in modern health care. " https://lnkd.in/e8KvU6Jq
The Center for Biosimilars’ Post
More Relevant Posts
-
Clinical research empowers us to discover new treatments, therapies, and cures. By systematically investigating and studying interventions, researchers pave the way for groundbreaking advancements in healthcare. Join us in honoring the dedication and innovation of clinical researchers, who work tirelessly to improve lives worldwide. 🔬🌍 🩺 Medcare Pharma: Your Way to Cure Contact us: ☎️ | 1-866-4-MEDICINE 📧 | info@medcarepharma.care 🌐 | https://lnkd.in/gA9pPUVR #clinicaltrialsupport #pharmacy #clinicaltrial #clinicalresearch #medicalresearch #clinicalstudies #clinicalstudy #healthcare #medcarepharma #researchstudies
-
-
British Columbia's Biosimilars Initiative has successfully saved about $732 million over five years by transitioning over 40,000 patients from reference biologics to biosimilars, without compromising health outcomes. This incredible achievement was not merely due to changing prescriptions, but thanks to a comprehensive program for patients and physicians. Key aspects of the initiative included: 🔄 6-month transition period 📜 A requirement for a new prescription from a prescriber for the switch 💬 Support fees for prescribers and pharmacists assisting patients 📝 Patient lists for prescribers 🔍 Consultations with patient groups, clinicians, professional bodies, insurers, and drug sponsors 📚 Educational and support tools for patients and healthcare providers 📢 Coordinated communications 📊 Monitoring biosimilar utilization ❗Exceptional coverage for patients unable to switch for clinical reasons ⛔ Delisting reference biologics after the transition period With adoption rates of 91%-95% within 24 months, BC's model exemplifies effective biosimilar adoption for cost savings and improved patient care, setting a precedent for other regions. Explore how we integrate patient insights into clinical trials and healthcare solutions: >> https://lnkd.in/dfGc_2TC >> https://lnkd.in/dc4kXmjw #biosimilars #patients #clinicalresearch #clinicaltrials #healthcare #biotech
-
-
New insights from #ESC2024 on managing severe hypertriglyceridaemia. 🌍🩺 Join experts Prof Gerald Watts & Prof Robert Rosenson to explore the latest strategies and practical steps for clinicians. Watch the series here 🔗 https://ow.ly/nQSj50Txgxw #CardioVascular #Healthcare #MedicalEducation Supported by an unrestricted educational grant from Arrowhead Pharmaceuticals
-
-
Medicine cures diseases, but doctors cure patients. This National Doctors' Day, ZIM Labs celebrates the heroes, whose wings of compassion and stethoscopes of expertise uplift spirits and mend hearts. Join us in expressing gratitude to doctors everywhere for their extraordinary contributions to healthcare. Visit https://www.zimlab.in/ to know more. #Doctor #NationalDoctorsDay #DoctorDay #ZIMLabs #Pharmaceuticals #InnovationInPharmaceuticals #ResearchAndDevelopment #PharmaIndustry #HealthScience #PharmaceuticalSolutions #PharmaceuticalResearch #ClinicalTrial
-
-
Clinical Pharmacology, First in Human, Proof of Mechanism, Proof of Concept and Bioanalysis
Renal and hepatic impairment studies are still a requirement during the development lifecycle of many drugs - even some newer modalities. This video gives a nice overview of some key considerations and capabilities.
Discover how Celerion’s expertise drives success in renal and hepatic insufficiency studies. Hear from Abbey Townsend, our Senior Director of Global Clinical Development, as she breaks down key challenges and strategies for managing PK studies efficiently and cost-effectively. Watch now to see how our partnerships with top investigators help navigate these complex trials! Contact us to learn how we can support your next drug development program: https://lnkd.in/eznFHuwS #ClinicalResearch #RenalStudies #HepaticStudies #Pharmacokinetics #CRO
-
Discover how Celerion’s expertise drives success in renal and hepatic insufficiency studies. Hear from Abbey Townsend, our Senior Director of Global Clinical Development, as she breaks down key challenges and strategies for managing PK studies efficiently and cost-effectively. Watch now to see how our partnerships with top investigators help navigate these complex trials! Contact us to learn how we can support your next drug development program: https://lnkd.in/eznFHuwS #ClinicalResearch #RenalStudies #HepaticStudies #Pharmacokinetics #CRO
-
Biosimilars are emerging as a transformative force in healthcare, reshaping the way we approach and access medical treatments. They are reducing costs and improving access to vital treatments all over the world. Read more about how biosimilars are reshaping medicine in our latest blog here: https://lnkd.in/eivU2G7t #blog #medicine #biosimilars #pharma #generics
-
How are participants recruited for clinical trials? Clinical Research Series - Day 16 👉Follow to get more... Knowledge on Clinical Research #au3macademy #learnwithau3m #au3mlifesciences #pharma #clinicaltrial #clinicalresearch #lifescince #clinicaldata #clinicalresearchjobs #clinicalresearchmatters #healthcare #clinicalresearchers #clinicalresearchtrials #clinicalresearchcareers #clinicaltrials #clinicalresearchtraining #clinicalresearchassociate
-
-
What are observational studies? Clinical Research Series - Day 5 👉 Follow to get more... Knowledge on "Clinical Research" #au3macademy #learnwithau3m #au3mlifesciences #pharma #clinicaltrial #clinicalresearch #lifescince #clinicaldata #clinicalresearchjobs #clinicalresearchmatters #healthcare #clinicalresearchers #clinicalresearchtrials #clinicalresearchtraining
-
-
| Gold Medalist PharmD (UOK) | xMacter International Limited | xICPAS | UN Ambassador | Delegate & Public Speaker | Researcher | AI Learner | Pharmaceutical Marketing |
Hey everyone! I am extremely excited to share with you all the short video about the personalized medication. Personalized medication is a new innovation in healthcare that is revolutionizing the way we treat patients. This innovation tailors the medication to the individual patient's genetic makeup, medical history, and lifestyle, resulting in more effective treatments with fewer side effects. The personalized medication has the potential to transform the pharmaceutical industry and the healthcare sector as a whole by improving patient outcomes and reducing healthcare costs. With this innovation, we can expect to see a shift towards more targeted therapies and personalized care. I have recently uploaded an article on Personalized Medication: A New Dawn in Healthcare and this video is a short summary of the article highlighting the main points. If you want to read the entire article and learn more about the impact of personalized medication, please check out the link below https://lnkd.in/dp8TtuE4. Let's join the conversation and stay up to date with the latest healthcare innovation. #PersonalizedMedication #HealthcareInnovation #LeadershipinHealthcare #PatientCareMatters #PatientHealthcare #PharmaceuticalIndustryNews #PharmaMarketingStrategies
